Commission Implementing Regulation (EU) 2015/1106 of 8 July 2015 amending Implementing Regulations (EU) No 540/2011 and (EU) No 1037/2012 as regards the conditions of approval of the active substance isopyrazam (Text with EEA relevance)
Text
Article-level text, parsed from the formex manifestation.
Article 1 Amendments to Implementing Regulation (EU) No 540/2011
In the column ‘Specific provisions’ of row 27, isopyrazam, of Part B of the Annex to Implementing Regulation (EU) No 540/2011, the last paragraph is replaced by the following: ‘The applicant shall submit to the Commission, the Member States and the Authority this information by 31 July 2017.’
Article 2 Amendments to Implementing Regulation (EU) No 1037/2012
In the column ‘Specific provisions’ of the Annex to Implementing Regulation (EU) No 1037/2012, the last paragraph is replaced by the following: ‘The applicant shall submit to the Commission, the Member States and the Authority this information by 31 July 2017.’
Article 3 Entry into force
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
Relations
What this act cites, and what cites it.
Show relationsVersions
Point-in-time consolidated versions of this act.
Show versions